Alessandra Mangia Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2019

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Mangia Research Topics

Disease

36	Infections 04/2024 - 01/2006
33	Fibrosis (Cirrhosis) 01/2024 - 03/2007
22	Chronic Hepatitis C 04/2024 - 07/2002
11	Liver Diseases (Liver Disease) 01/2023 - 05/2013
11	Hepatitis C 01/2022 - 01/2008
8	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 05/2007
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 06/2009
6	Chronic Hepatitis B 01/2021 - 10/2002
5	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2016
5	Hepatitis 01/2019 - 07/2002
4	COVID-19 11/2021 - 11/2020
4	Neoplasms (Cancer) 01/2015 - 08/2011
3	Fatigue 01/2017 - 05/2013
2	Nausea 01/2024 - 05/2013
2	Disease Progression 10/2022 - 06/2021
2	Fatty Liver 01/2020 - 05/2005
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 07/2002
2	Chronic Disease (Chronic Diseases) 01/2017 - 10/2016
2	Body Weight (Weight, Body) 12/2010 - 06/2005
1	Diarrhea 01/2024
1	Hepatitis D 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Reinfection 01/2023
1	Breakthrough Infections 01/2022
1	Alcoholic Fatty Liver 06/2021
1	Hepatitis B 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Portal Hypertension 01/2019
1	Inflammation (Inflammations) 01/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Virus Diseases (Viral Diseases) 12/2016
1	Hemorrhage 01/2016

Drug/Important Bio-Agent (IBA)

27	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 07/2002
18	SofosbuvirIBA 04/2024 - 05/2013
18	Antiviral Agents (Antivirals)IBA 01/2023 - 02/2009
14	InterferonsIBA 11/2019 - 07/2002
13	velpatasvirIBA 04/2024 - 12/2015
7	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2009
7	VaccinesIBA 01/2022 - 01/2015
5	sofosbuvir drug combination ledipasvirIBA 01/2021 - 05/2014
4	telaprevirIBA 01/2017 - 06/2013
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 05/2005
3	Hepatitis B e AntigensIBA 01/2023 - 01/2018
3	AntigensIBA 10/2021 - 01/2015
3	Interferon LambdaIBA 12/2020 - 08/2014
3	TabletsIBA 01/2019 - 07/2015
3	ledipasvirIBA 01/2017 - 05/2014
3	CytokinesIBA 01/2015 - 07/2010
3	NucleotidesIBA 05/2014 - 05/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2011
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
2	peginterferon alfa-2a (Pegasys)FDA Link 01/2017 - 05/2013
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2017 - 01/2014
2	peginterferon alfa-2b (Pegintron)FDA Link 02/2011 - 06/2005
2	Interferon-alpha (Interferon Alfa)IBA 03/2007 - 07/2002
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2024
1	resmetiromIBA 01/2024
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	AcidsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	BNT162 VaccineIBA 08/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 12/2021
1	glecaprevir and pibrentasvirIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Hepatitis C AntibodiesIBA 11/2020
1	Protons (Proton)IBA 01/2020
1	micaIBA 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	ProteomeIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	vesatolimodIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	EnzymesIBA 01/2017
1	AcyltransferasesIBA 01/2017
1	Silybin (Lagosa)IBA 04/2016
1	Genetic Markers (Genetic Marker)IBA 02/2016
1	LipidsIBA 01/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	rice nuclear protein GT-2 (GT-2)IBA 01/2016
1	microsomal triglyceride transfer proteinIBA 01/2016
1	daclatasvirIBA 01/2016
1	ChemokinesIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015

Therapy/Procedure

28	Therapeutics 01/2022 - 10/2002
6	Duration of Therapy 01/2015 - 01/2008
3	Aftercare (After-Treatment) 01/2018 - 10/2016
2	Blood Transfusion (Blood Transfusions) 08/2014 - 01/2011
1	Drug Prescriptions 01/2023
1	Liver Transplantation 06/2021
1	Withholding Treatment 01/2017
1	Opiate Substitution Treatment 12/2016
1	Contraindications 01/2016